These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 34649459)
1. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial. Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB; Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459 [TBL] [Abstract][Full Text] [Related]
2. Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups. Diener HC; Sacco RL; Easton JD; Granger CB; Bar M; Bernstein RA; Brainin M; Brueckmann M; Cronin L; Donnan G; Gdovinová Z; Grauer C; Kleine E; Kleinig TJ; Lyrer P; Martins S; Meyerhoff J; Milling T; Pfeilschifter W; Poli S; Reif M; Rose DZ; Šaňák D; Schäbitz WR Stroke; 2020 Jun; 51(6):1758-1765. PubMed ID: 32404035 [TBL] [Abstract][Full Text] [Related]
3. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS. Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190 [TBL] [Abstract][Full Text] [Related]
4. Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial. Del Brutto VJ; Diener HC; Easton JD; Granger CB; Cronin L; Kleine E; Grauer C; Brueckmann M; Toyoda K; Schellinger PD; Lyrer P; Molina CA; Chutinet A; Bladin CF; Estol CJ; Sacco RL J Am Heart Assoc; 2022 Jun; 11(11):e023545. PubMed ID: 35656979 [TBL] [Abstract][Full Text] [Related]
5. Nonstenotic Carotid Plaque in Embolic Stroke of Undetermined Source: Interplay of Arterial and Atrial Disease. Grosse GM; Sieweke JT; Biber S; Ziegler NL; Gabriel MM; Schuppner R; Worthmann H; Bavendiek U; Weissenborn K Stroke; 2020 Dec; 51(12):3737-3741. PubMed ID: 33040704 [TBL] [Abstract][Full Text] [Related]
6. Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source: RE-SPECT ESUS Subgroup Analysis. Uchiyama S; Toyoda K; Lee BC; Liou CW; Wong LKS; Grauer C; Brueckmann M; Taniguchi A; Urano Y; Easton JD; Stroke; 2021 Mar; 52(3):1069-1073. PubMed ID: 33588594 [TBL] [Abstract][Full Text] [Related]
7. Identification of patients with embolic stroke of undetermined source and low risk of new incident atrial fibrillation: The AF-ESUS score. Ntaios G; Perlepe K; Lambrou D; Sirimarco G; Strambo D; Eskandari A; Karagkiozi E; Vemmou A; Korompoki E; Manios E; Makaritsis K; Vemmos K; Michel P Int J Stroke; 2021 Jan; 16(1):29-38. PubMed ID: 32423317 [TBL] [Abstract][Full Text] [Related]
8. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS). Diener HC; Easton JD; Granger CB; Cronin L; Duffy C; Cotton D; Brueckmann M; Sacco RL; Int J Stroke; 2015 Dec; 10(8):1309-12. PubMed ID: 26420134 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407 [TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation in embolic stroke of undetermined source: role of advanced imaging of left atrial function. Chousou PA; Chattopadhyay R; Ring L; Khadjooi K; Warburton EA; Mukherjee T; Bhalraam U; Tsampasian V; Potter J; Perperoglou A; Pugh PJ; Vassiliou VS Eur J Prev Cardiol; 2023 Dec; 30(18):1965-1974. PubMed ID: 37431922 [TBL] [Abstract][Full Text] [Related]
11. Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Source - Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial. Toyoda K; Uchiyama S; Hagihara Y; Kuwashiro T; Mori T; Kamiyama K; Urano Y; Taniguchi A; Nozaki K; Cronin L; Grauer C; Brueckmann M; Diener HC Circ J; 2020 Nov; 84(12):2286-2295. PubMed ID: 33132228 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28729407 [TBL] [Abstract][Full Text] [Related]
13. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. Diener HC; Sacco RL; Easton JD; Granger CB; Bernstein RA; Uchiyama S; Kreuzer J; Cronin L; Cotton D; Grauer C; Brueckmann M; Chernyatina M; Donnan G; Ferro JM; Grond M; Kallmünzer B; Krupinski J; Lee BC; Lemmens R; Masjuan J; Odinak M; Saver JL; Schellinger PD; Toni D; Toyoda K; N Engl J Med; 2019 May; 380(20):1906-1917. PubMed ID: 31091372 [TBL] [Abstract][Full Text] [Related]